The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
- Resource Type
- Article
- Source
- In
Radiotherapy and Oncology March 2024 192 - Subject
- Language
- ISSN
- 0167-8140